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Objective: Body mass index (BMI) and waist circumference 
(WC) as measures of obesity have some limitations. The aim 
of this study was to evaluate whether one measure could 
predict the presence of diastolic dysfunction (DD) more accu-
rately than the other measures.
Methods: A total of 91 obese patients without any other risk 
factors for DD were prospectively enrolled. Echocardiographic 
examination was performed. DD was defined and categorized 
according to recent guidelines. The study participants were di-
vided into 2 groups according to the presence of DD. Weight, 
height, and WC were measured; BMI and waist-to-hip ratio 
(WHR) were calculated; and a body shape index (ABSI) was 
calculated as WC/(BMI2/3height1/2). The associations between 
ABSI, BMI, WHR, and WC and the presence of DD were ex-
amined using logistic regression analyses. Analysis of covari-
ance was used to examine the differences.
Results: WC and BMI were significantly greater in subjects 
with DD (p=0.049 and 0.051, respectively). A greater BMI, 
WC, and WHR increased the risk of the presence of DD (BMI-
DD: odds ratio [OR]=1.096, p=0.024; WC-DD: OR=1.059, 
p=0.007; WHR-DD: OR=2.363, p=0.007). After adjustment for 
age and sex, only BMI continued to be significantly associated 
with DD (p=0.031). ABSI was not associated with DD.
Conclusion: After adjustment for age and sex, BMI was the 
only predictor of DD in obesity. Despite its limitations, BMI 
may still be a potentially more accurate measure of DD com-
pared with other obesity measures.
Amaç: Vücut kitle indeksi ve bel çevresinin obezitenin değer-
lendirilmesinde bazı kısıtlılıkları vardır. Bu çalışma bir obezite 
ölçümünün diyastolik disfonksiyonun (DD) varlığını diğer obe-
zite ölçümlerinden daha doğru öngörüp öngörmediğini değer-
lendirmeyi amaçladı.
Yöntemler: Diyastolik disfonksiyon için herhangi bir risk faktö-
rü olmayan 91 obez denek çalışmaya alındı. Ekokardiyografik 
inceleme yapıldı. DD, en güncel kılavuzlara göre tanımlandı 
ve sınıflandırıldı. Denekler DD varlığına göre iki gruba ayrıl-
dılar. Kilo, boy ve bel çevresi (BÇ) ölçüldü. Vücut kitle indek-
si (VKİ) ve bel kalça oranı (BKO) hesaplandı. Bir vücut şekil 
indeksi (VŞİ), BÇ/(VKİ2/3boy1/2) denklemine göre hesaplandı. 
Lojistik regresyon analizi ile VŞİ, VKİ, BKO ve BÇ’nin DD ile 
ilişkisini inceledik. İki grup arasındaki farkın incelenmesi için 
kovaryans analizi kullanıldı.
Bulgular: Bel çevresi ve VKİ, DD’si olan deneklerde anlamlı 
olarak artmıştı (sırasıyla, p=0.049 ve 0.051). Artmış VKİ, BÇ ve 
BKO DD olma riskini arttırdı [BMI-DD: odds oranı (OR)=1.096, 
p=0.024; WC-DD: OR=1.059, p=0.007; WHR-DD: OR=2.363, 
p=0.007]. Yaş ve cinsiyet düzeltmesinden sonra sadece VKİ 
anlamlı olarak DD ile ilişkili olmaya devam etti (p=0.031). VŞİ 
DD ile ilişkili değildi.
Sonuç: Yaş ve cinsiyet düzeltmesinden sonra VKİ obezitede 
DD’nin tek öngördürücüsü idi. Tüm kısıtlılıklarına rağmen VKİ 
halen potansiyel olarak DD’nin diğer obezite ölçümleri içinde 
en doğru ölçümü olabilir.
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ABSTRACT ÖZET
ORIGINAL ARTICLE
Obesity is a well-known risk factor for diastolic dysfunction (DD).[1] Although body mass index 
(BMI) is widely used as a measure of obesity, it has 
potential weaknesses. To partly overcome these weak-
nesses, waist circumference (WC) is used as an indi-
cator of abdominal fat accumulation. However, WC 
reflects not only abdominal fat accumulation but also 
overall body size (height and weight). Chronic heart 
failure is a major health problem with an increasing 
prevalence, morbidity, and mortality throughout the 
world. DD may account for more than half of these 
cases.[1] At present, echocardiography is the best non-
invasive tool to evaluate diastolic function and to es-
timate filling pressures. Identifying obese individuals 
who are at high risk for DD is potentially of signifi-
cant benefit, so that preventive measures can be ap-
plied. Findings concerning the relationship between 
several obesity measures and cardiovascular disease 
morbidity or mortality have been inconsistent.[2,3] 
Krakauer et al.[4] described a new obesity measure, a 
body shape index (ABSI), which quantifies abdomi-
nal adiposity relative to BMI and height. To date, sev-
eral cohort studies have evaluated the ABSI regard-
ing the prediction of morbidity and mortality.[5–7] One 
indicated that the ABSI was significantly associated 
with total stroke incidence in men, while BMI was 
not.[5] Another reported that among different obesity 
measures, ABSI revealed a stronger association with 
total, cardiovascular, and cancer mortality.[8] Another 
demonstrated that ABSI was the strongest predictor of 
all-cause mortality among the obesity measurements.
[9] Others found that ABSI was valuable for the pre-
diction of the development of diabetes[6] or hyperten-
sion,[7] although the predictive power was no better 
than WC or BMI. The aim of this study was to ex-
amine the predictive power of ABSI, BMI, WC, and 
waist-to-hip ratio (WHR) for DD in obese individuals 
without any cardiovascular risk factors.
METHODS
Patients
The study design was prospective, and included 91 
obese individuals without any cardiovascular risk fac-
tors. The exclusion criteria were coronary artery dis-
ease (visible coronary stenosis >20% in at least 1 coro-
nary artery on angiography, myocardial infarction, 
and/or percutaneous or surgical re-vascularization), 
stroke, transient ischemic attack, peripheral arterial 
disease, moderate 
(>2+) valvular re-
gurgitation or any 
valvular stenosis, 
any rhythm other 
than sinus rhythm, 
systolic dysfunction 
(ejection fraction 
<50%), insufficient 
echocardiographic 
imaging, myocardial 
wall thinning or mo-
tion abnormalities 
(seen on echocar-
diography and suggestive of previous myocardial in-
farction), anemia, renal failure, hepatic failure, preg-
nancy or lactation, regular use of alcohol, current or 
past smoking, any systemic inflammatory condition, 
history of risk factors for DD (including hyperten-
sion, atherosclerotic cardiovascular disease, diabetes 
mellitus, obstructive sleep apnea, hyperlipidemia, 
and metabolic syndrome), and major systemic or 
psychiatric disease. The study participants were not 
taking any medication, including oral contraceptive 
pills. This study was approved by the medical ethics 
committee of the participating university (protocol 
number: 60116787/020/27531) and was conducted in 
accordance with the Helsinki Declaration. Informed 
consent was obtained from all of the members of the 
study group.
The participants were weighed and their height was 
measured, and then body mass index (BMI) was cal-
culated as weight in kilograms divided by the square 
of height in meters. Obesity was defined as BMI >30 
kg/m2. ABSI was calculated as WC / (BMI2/3height1/2), 
with WC and height in meters.[4] WC (cm) was mea-
sured midway between the lowest rib and the iliac crest 
while the participants were standing upright. Fasting 
plasma glucose and insulin level measurements were 
obtained for all of the participants. The homeostasis 
model assessment of insulin resistance (HOMA-IR) 
was calculated using the following formula: (fasting 
plasma glucose X fasting plasma insulin) / 22.5.[10] 
The state of insulin resistance was determined using 
the cutoff value of 2.7. 
Echocardiographic analysis
A comprehensive echocardiography examination was 
performed for each participant while at rest in the left 
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Abbreviations:
ABSI  A body shape index
BMI  Body mass index
BSA  Body surface area
CI	 	 Confidence	interval
E/é	 	 Ratio	between	early	mitral
	 	 inflow	velocity	and	mitral
	 	 annular	early	diastolic	velocity
DD	 	 Diastolic	dysfunction	
HOMA-IR	 Homeostasis	model	assessment		
	 	 of	insulin	resistance
LV	 	 Left	ventricle	
TR	 	 Tricuspid	regurgitation	
WC	 	 Waist	circumference	
WHR	 	 Waist-to-hip	ratio
OR	 	 Odds	ratio
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lateral decubitus position using standard views on a 
Vivid 7 echocardiography device (GE Healthcare, 
Inc. Chicago, IL, USA). Left ventricle (LV) internal 
dimensions and wall thickness were measured using 
2-dimensional M-mode guided echocardiographic 
tracings obtained at mid-chordal level in the paraster-
nal long-axis view according to the American Soci-
ety of Echocardiography criteria.[11] The LV ejection 
fraction was calculated using the modified Simpson 
method. Mitral inflow velocities were obtained with 
pulse-wave Doppler ultrasound in the apical 4-cham-
ber view with the sample volume positioned at the 
tips of the mitral valve leaflets. The peak early and 
late diastolic mitral inflow velocity and maximal tri-
cuspid regurgitation (TR) velocity were measured 
and averaged over 3 cardiac cycles. The ratio of early 
diastolic to late diastolic mitral inflow velocities was 
calculated. The E wave deceleration time and isovol-
umetric relaxation time were measured. Myocardial 
velocity profiles of the lateral and septal mitral annuli 
were obtained by positioning the sample volume at 
the junction of the mitral annulus and the respective 
wall. The peak mitral annular early diastolic veloci-
ties were measured and averaged over 2 consecutive 
cardiac cycles. The mean value of the septal and lat-
eral annulus early diastolic velocity was calculated. 
The ratio between early mitral inflow velocity and 
mitral annular early diastolic velocity was calculated 
(E/é). Maximal left atrial volumes were obtained with 
the apical 4-chamber view and the disc summation 
method at the mitral valve opening and indexed for 
body surface area (BSA). The type and severity of 
DD was classified according to the combination of 
LV diastolic parameters, including transmitral inflow, 
myocardial tissue velocity, isovolumetric relaxation 
time, deceleration time, E/é mean septal-lateral, max-
imal TR velocity, and maximal LA volume index.[12–15] 
Grade I DD was defined as an E/A ratio of ≤0.8 along 
with a peak E velocity of ≤50 cm/second, an E/A ra-
tio of ≤0.8 with a peak E velocity of >50 cm/second, 
an E/A of 0.8 - <2 with 2 of 3 or all 3 of the follow-
ing criteria below the cutoff values: average E/é >14, 
maximal TR velocity >2.8 m/second, and maximal 
LA volume index of >34 mL/m2. Grade II DD was 
characterized as E/A ≤0.8 with peak E velocity of >50 
cm/second or E/A 0.8 - <2 with 2 of 3 or all of the pre-
viously mentioned criteria meeting the cutoff values.
[13] All of the echocardiographic results were analyzed 
by a single cardiologist (Y.T.Y.) who was blinded to 
the clinical and laboratory characteristics of the pa-
tients. Intraobserver variability of <5% was accepted 
for the echocardiographic measurement.
Statistical analysis
The statistical software package, PASW Statistics 
for Windows, Version 18.0 (SPSS Inc., Chicago, IL, 
USA), was used to perform all analyses. Continuous 
and categorical data were reported as mean±SD and 
percentages, respectively. Intergroup comparisons 
were performed using an independent samples t-test 
(e.g., age) or the Mann-Whitney U-test for continuous 
variables, and a chi-square test for categorical vari-
ables (e.g., sex).
Normal distribution of the data was assessed with 
the Shapiro-Wilk test. Analysis of covariance for ad-
justment was applied for age and to examine differ-
ences between groups with and without DD, because 
age differed between the groups. Therefore, the re-
sults of the analysis of covariance were given with 
standard error values in the tables. A sex category was 
not included in the analysis of covariance because the 
sex distribution did not differ significantly between 
the groups. To determine the risk factors influencing 
DD, binary and multiple logistic regression methods 
were used. Both age and sex were included in logistic 
regression models. Statistical significance was deter-
mined at p<0.05.
RESULTS
The sample included 91 asymptomatic obese indi-
viduals with no risk factors for DD. The participants 
were divided into 2 groups according to the presence 
of DD as per the recent guidelines.[1] There were 49 
subjects with normal diastolic function and 42 with 
grade I DD (impaired relaxation). Clinical and labo-
ratory characteristics are listed in Table 1. Age, WC, 
and BMI were significantly greater in subjects with 
DD (p<0.001, 0.049, and 0.051, respectively). The 
WC value differed between groups both before and 
after adjustment for age. The WHR differed between 
groups only before adjustment for age. The BMI value 
differed only after adjustment for age. Therefore, BMI 
can be considered to have a significant effect on DD. 
The ABSI measurement did not differ between groups 
either before or after adjustment for age.
The binary logistic regression analysis results are 
provided in Table 2. Before the adjustment for age and 
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had no effect on DD after adjustment for age and gen-
der. The intra-observer variability was less than 5% for 
all of the echocardiographic measurements.
The agreement between predictions for DD based 
on the constructed models and the actual results for 
gender, BMI, WC, and WHR appeared to have a signif-
icant effect on DD, while ABSI did not have any effect 
on DD. After adjustment for age and gender, only BMI 
had a significant effect on DD (Table 2). A greater BMI 
increased the risk for DD 1.104 times. WC and WHR 
Table 1. Clinical and laboratory characteristics of the patients (n=91)
   Diastolic dysfunction (+) (n=42) Diastolic dysfunction (-) (n=49)  
   Mean±SE Mean±SE p
Age, years 47±2 36±2 <0.001*†
Male, n (%) 9 (21%) 5 (10%) 0.139‡
Waist circumference (cm) 108±2 103±2 0.049*§
Waist circumference-hip ratio 0.68±0.01 0.65±0.01 0.119§
Body mass index (kg/m2) 37±1 34±1 0.051*§
Height (cm)  159±1 159±1 0.613§
Weight (kg) 94±3 87±2 0.038*§
A body shape index 0.78±0.01 0.77±0.01 0.824§
Laboratory measurements      
 Total cholesterol (mg/dL) 190.47±6.38 196.4±5.79 0.514§
 HDL-C (mg/dL)  44.54±2.39 53.57±2.17 0.009*§
 LDL-C (mg/dL) 112.89±5.12 116.7±4.64 0.601§
 Triglycerides (mg/dL) 170.45±15.85 131.44±14.37 0.086§
 Fasting glucose (mg/dL) 97.8 ±1.92 99.74±1.74 0.477§
 Insulin (uIU/mL) 13.28±1.28 15.5±1.13 0.222§
 HOMA-IR 3.2±0.34 3.88±0.3 0.151§
 Creatinin (mg/dL) 0.66±0.02 0.63±0.02 0.352§
Echocardiographic indices   
 TR velocity (m/s) 1.92±0.03 1.92±0.03 0.212§ 
 LA volume index (ml/m2) 28±1  17±0 <0.001*§
MV-inflow   
 MV-E (m/s) 0.77±0.03 0.82±0.03 0.283§
 MV-A (m/s) 0.74±0.02 0.65±0.02 0.632§
 E/A ratio  1.06±0.05 1.29±0.05 0.003*§
 Deceleration time (m/s) 266±5 203±4 <0.001*§
 IVRT (m/s) 149±3 66±2 <0.001*§
Tissue Doppler   
 é septal (m/s) 0.065±0.003  0.13±0.003 <0.001*§
 é lateral (m/s) 0.08±0.02 0.16±0.01 0.001*
 e’ mean septal-lateral (m/s) 0.1±0.01 0.13±0.01 0.055§
 E/e’ mean septal-lateral 9.5±0.37 6.29±0.34 <0.001*§
HDL-C: High-density lipoproptein cholesterol; IVRT: Isovolumic relaxation time; LDL-C: Low-density lipoprotein cholesterol; HOMA-IR: Homeostasis model 
assessment of insulin resistance; LA: Left atrial; MV-A: Mitral valve late diastolic inflow; MV-E: Mitral valve early diastolic inflow; e′: Early diastolic tissue 
velocity; E/e′: Ratio between early mitral inflow velocity and mitral annular early diastolic velocity; SE: Standard error; TR: Tricuspid regurgitation.
*p<0.05 statistically significant; †: Independent samples t-test; ‡: Chi square test; §: Analysis of covariance (Covariates appearing in the model are evaluated 
at age=41.14 years).
DD was statistically significant (Table 3). The best re-
sult was predicted with Model 4 (age, gender, WHR). 
However, when examined with the results of logis-
tic regression analysis, BMI provided better results 
than WHR in terms of consistency. The correct clas-
sification ratio and Kappa values were very similar 
in Models 1 and 4, indicating that the predictions of 
WHR and BMI for DD were very close.
DISCUSSION
The main findings of this study are: (1) WC and BMI 
were significantly greater in subjects with DD, (2) a 
greater BMI, WC, and WHR, but not ABSI, were as-
sociated with DD, and (3) after adjustment for age and 
gender, BMI was the variable that predicted DD in 
obesity. BMI can still be a useful tool to identify DD 
in obese individuals without risk factors, despite its 
limitations.
To the best of our knowledge, this study is the first 
to look at ABSI as a predictor for DD in obese individ-
uals without any risk factor for DD. Heart failure has 
been a rapidly growing epidemic in recent years. DD 
and its progression are independent predictors of the 
incidence of heart failure.[16] Obesity is defined as an 
excess of body fat and is a known risk factor for DD.[1] 
Obesity is associated with altered LV remodeling, 
Measures of obesity and diastolic dysfunction 655
Table 2. Binary and multiple logistic regression analyses to determine the effects of variables on diastolic dysfunction 
Model Variables SE Wald p OR 95% CI for EXP(B)
      Lower Upper
Univariate BMI 0.041 5.082 0.024* 1.096 1.012 1.186
Univariate ABSI 0.448 1.844 0.174 1.838 0.764 4.424
Univariate WC 0.021 7.196 0.007* 1.059 1.016 1.104
Univariate WHR 0.321 7.168 0.007* 2.363 1.259 4.433
Multivariate Model 1 Age 0.024 13.333 <0.001* 1.09 1.041 1.141
 Gender 0.728 2.713 0.1 3.319 0.796 13.833
 BMI 0.046 4.637 0.031* 1.104 1.009 1.209
Multivariate Model 2 Age 0.025 13.881 <0.001* 1.097 1.045 1.153
 Gender 0.812 1.087 0.297 2.331 0.475 11.442
 ABSI 0.597 0.059 0.809 0.865 0.268 2.791
Multivariate Model 3 Age 0.024 12.445 <0.001* 1.088 1.038 1.14
 Gender 0.739 0.393 0.531 1.589 0.374 6.756
 WC 0.025 3.195 0.074 1.045 0.996 1.097
Multivariate Model 4 Age 0.024 11.225 0.001* 1.085 1.034 1.137
 Gender 0.731 1.517 0.218 2.461 0.587 10.314
 WHR 0.372 2.77 0.096 1.859 0.896 3.857
ABSI: A body shape index; BMI: Body mass index; CI: Confidence interval; OR: Odds ratio; SE: Standard error; WC: Waist circumference; WHR: Waist-to-
hip ratio. *Significant.
Table 3. Agreement between the constructed models for diastolic dysfunction and the actual results
  CCR Sensitivity Specificity PPV NPV Kappa (p) McNemar
Model 1 75.6 68.3 81.6 75.7 75.5 0.503 (<0.001) 0.523
Model 2 72.1 69.2 74.5 69.2 74.5 0.437 (<0.001) 1
Model 3 70.9 66.7 74.5 68.4 72.9 0.412 (<0.001) 1
Model 4 76.7 71.8 80.9 75.7 77.6 0.529 (<0.001) 0.824
CCR: Correct classification ratio; NPV: Negative predictive value; PPV: Positive predictive value.
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DD. The results of epidemiological studies that have 
reported this characteristic of anthropometric indices 
are inconsistent. In this study, BMI was a better pre-
dictor of DD than WHR, ABSI, or WC. Krakauer and 
Krakauer[3] have shown that despite small differences 
in the odds ratios, total mortality was considerably 
better predicted by ABSI than by BMI, WC, WHR, 
or waist-to-height-ratio. Though there are a small 
number of studies evaluating the potential of ABSI 
to predict the risk of mortality or diseases, there is 
no consensus if this measure is better than BMI or 
WC. He and Chen[6] found ABSI to be independently 
capable of anticipating the onset of diabetes melli-
tus among a Chinese population, although it was not 
more accurate than BMI and WC. Other studies have 
also not observed ABSI to be better than WC and/or 
BMI in the evaluation of the risk of cardiovascular 
disease,[27] cardiovascular disease mortality,[2] inci-
dent hypertension,[28] diabetes,[29] dyslipidemia,[29] or 
metabolic syndrome.[27] One study did not demon-
strate ABSI as a predictor of cardiovascular disease.
[30] Recently, one study showed that among other 
anthropometric measures, ABSI had a stronger rela-
tionship to total, cardiovascular, and cancer mortality. 
However, the added predictive value of ABSI in the 
prediction of mortality was limited.[8] In contrast, a 
study conducted among a European population indi-
cated that WC and WHR were stronger predictors for 
CVD mortality than BMI and ABSI.[2] ABSI had not 
been found to add consistently to the predictive val-
ues of other anthropometric measures in cardiovas-
cular disease prediction.[9] Another study conducted 
in a middle-aged, and older Indonesian population 
group reported that ABSI was less strongly associ-
ated with incident hypertension than WC and BMI.
[28] In contrast, in a sample of Portuguese adolescents, 
ABSI explained variance in blood pressure better than 
WC and BMI. As such, when examining the effect of 
weight status on blood pressure, considering use of 
ABSI alongside BMI would be justified.[31] The un-
derlying mechanism of these conflicting results is not 
clear. However, ethnic and gender differences might 
be a possible explanation for some of the contrasting 
findings. Another possibility may be patients’ clinical 
characteristics, i.e., the presence of other risk factors 
for DD. For example, in participants with multiple 
comorbidities, central obesity has been found to be 
associated with adverse cardiac mechanics.[32] Most of 
these studies do not appear to have transformed ABSI 
possibly due to increased hemodynamic load, neuro-
hormonal activation, and increased cytokine produc-
tion.[17] It is important to identify high-risk individuals 
early to recognize those who need further evaluation. 
DD may be affected not only by the amount of body 
fat, but also by its distribution. Various studies have 
reported that patients with more abdominal fat will 
have higher risks of cardiovascular disease and other 
related diseases including hypertension, type 2 dia-
betes, and high cholesterol.[18,19] In the present study, 
BMI predicted the presence of DD better than other 
obesity indices. Lai et al.[20] have recently demon-
strated that increased visceral adiposity may be asso-
ciated with DD. They used multidetector computed 
tomography to quantify visceral adiposity. However, 
for quantifying abdominal obesity, WC has the ad-
vantage of being a simple anthropomorphic measure 
requiring only a measuring tape. ABSI uses the basic 
inputs of WC, height, and weight. However, in this 
study, neither WC nor ABSI predicted DD better than 
BMI after adjusting for age and gender. In light of 
the limited availability and high cost of more complex 
biochemical, genetic, or imaging technology, BMI 
can still be a useful tool in an improved assessment of 
risk related to obesity and body composition. Numer-
ous studies have examined the relationship between 
different indices of obesity and DD.[21–23] In a previous 
study of healthy volunteers, WC and BMI were both 
independently associated with LV DD.[21] One study 
showed that WC was second only to age in impact on 
an independent association with E/A in a population 
sample with a high prevalence of excess adiposity.[24] 
Another study indicated that increased WHR had a 
stronger association with lower LV ejection fraction 
and LV DD than BMI.[22] Russo et al.[23] reported that 
increased BMI was associated with worse LV dias-
tolic function independent of LV mass and associated 
risk factors. In another study, it was found that only 
WC remained significantly associated with LV DD 
after the adjustment for age, gender, and risk factors.
[21] Another study found BMI to be an independent 
predictor of LV DD, along with age, hypertension, 
and diabetes mellitus.[25] In contrast, Krishnan et al.[26] 
found no correlation between BMI and LV wall thick-
ness, fractional shortening, or pulmonary artery sys-
tolic pressure.
Obesity indices cannot fully distinguish visceral 
fat from subcutaneous fat. It is not clear which of 
these obesity indices has a stronger association with 
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ish H, Edvardsen T, et al. Recommendations for the Evaluation 
of Left Ventricular DiastolicFunction by Echocardiography: 
An Update from the American Society of Echocardiography 
and the European Association of Cardiovascular Imaging. Eur 
Heart J Cardiovasc Imaging 2016;17:1321–60. [CrossRef]
14. Caballero L, Kou S, Dulgheru R, Gonjilashvili N, 
Athanassopoulos GD, Barone D, et al. Echocardiograph-
ic reference ranges for normal cardiac Doppler data: results 
from the NORRE Study. Eur Heart J Cardiovasc Imaging 
2015;16:1031–41. [CrossRef]
15. Gilman G, Nelson TA, Hansen WH, Khandheria BK, Om-
men SR. Diastolic function: a sonographer’s approach to the 
into age and sex specific z scores as previously ad-
vocated.[4] Correction for age is particularly relevant, 
since mean ABSI increases from the youngest to the 
oldest adults by about 2 standard deviations of young 
adult ABSI.
Limitations
Our study had limitations. The study was cross-sec-
tional in design. There was no long-term follow-up 
of the patients. We did not evaluate diastolic function 
invasively. The predictive power of obesity indices 
could not be assessed for different severity levels of 
DD, as the 42 patients with DD in this study were 
all classified as grade I DD (impaired relaxation). We 
did not perform 24-hour blood pressure monitoring 
or a glucose tolerance test in every patient to rule out 
hypertension and diabetes, respectively. Other limita-
tions were the small sample size, which was predom-
inantly female and precluded gender analysis. Larger-
scale, longitudinal studies that include obese patients 
without any cardiovascular risk factors are needed to 
confirm the present findings.
Conclusion
In this study, we demonstrated that all 3 obesity mea-
sures, but not ABSI, determined the presence of DD. 
BMI showed the strongest association with DD. It 
may be a more accurate measure for identifying DD 
and could therefore better inform and guide treatment 
to improve obesity-related health.
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